0001213900-22-008953.txt : 20220223
0001213900-22-008953.hdr.sgml : 20220223
20220223161838
ACCESSION NUMBER: 0001213900-22-008953
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220222
FILED AS OF DATE: 20220223
DATE AS OF CHANGE: 20220223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lefkowitz Steven W
CENTRAL INDEX KEY: 0001313149
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34673
FILM NUMBER: 22663951
MAIL ADDRESS:
STREET 1: SIX HARRISON STREET
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CorMedix Inc.
CENTRAL INDEX KEY: 0001410098
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4200
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 908-517-9500
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4200
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
4
1
doc4.xml
PRIMARY DOCUMENT
X0306
4
2022-02-22
false
0001410098
CorMedix Inc.
CRMD
0001313149
Lefkowitz Steven W
C/O CORMEDIX INC.
300 CONNELL DRIVE, SUITE 4200
BERKELEY HEIGHTS
07922
true
false
false
false
Common Stock
60498.0000
D
Common Stock
30152.0000
I
Wade Capital Corp Money Purchase Plan
Common Stock
2000.0000
I
Reporting Person's Wife
Stock Option (Right to Buy Common Stock)
4.0300
2022-02-22
4
A
false
20000.0000
0.0000
A
2032-02-22
Common Stock
20000.0000
20000.0000
D
Stock Option (Right to Buy Common Stock)
8.3200
2031-01-11
Common Stock
30000.0000
30000.0000
D
Stock Option (Right to Buy Common Stock)
5.6300
2030-02-25
Common Stock
15000.0000
15000.0000
D
Stock Option (Right to Buy Common Stock)
8.3000
2029-01-10
Common Stock
15000.0000
15000.0000
D
Stock Option (Right to Buy Common Stock)
2.8500
2028-02-16
Common Stock
8000.0000
8000.0000
D
Stock Option (Right to Buy Common Stock)
2.2500
2027-06-25
Common Stock
15000.0000
15000.0000
D
The reporting person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which he has voting and investment control).
These options were granted on 1/11/2021. These options are fully vested.
These options were granted on 02/25/2020. These options are fully vested.
These options were granted on 01/10/2019. The options are fully vested.
These options were granted on 2/16/2018. These options are fully vested.
These options were granted on 6/25/2017. These options are fully vested.
These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.
/s/ Steven W Lefkowitz
2022-02-23